Disclosed is a medication for the prevention or treatment of inner ear disorders that comprises a spirohydantoin derivative represented by general formula (I) (wherein, X represents a halogen atom or a hydrogen atom, and R and R together or independently represent a hydrogen atom or an optionally substituted C alkyl group.) or a pharmacologically acceptable salt thereof as an active component.